Digital Edition

DIGITAL EDITION

Interactive BONUS content delivered to your email

CLICK HERE TO CONTINUE »

Non-Accredited Education

CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.

A Universal Classification System for Chronic Total Occlusions

The presence of a stem of patent vessel
longer than 10mm, with a tapering configuration
or a visible track and has no branches
originating within 5mm of the occlusion or e v idence
of calcification on fluoroscopy is classified
as a CTO with an “AO” grade.The presence of any of the following
such as a stem of patent vessel shorter than
10mm proximal to the occlusion, a blunt configuration
of the leading edge, no visible track,
the presence of branching vessels originating
within 5mm of the occlusion or eviThe presence of any of the following such as an ostial total occlusion, a total occlusion
precisely at a bifurcation point, significant calcification on fluoroscopy or a long lesion as
evidenced by retrograde filling of the distal segment is classified asA CTO with a “B1” grade
is defined as having any of the following
features: presence of bridging collateral
vessels, presence of an
aneurysmal appearance at the point of
occlusion or in close proximity, or the
absence of good distal vasculature as
seen by
VOLUME: 20 PUBLICATION DATE: Jun 01 2008
Sidebars_in_article: 
Issue Number: 
6
author: 

Rohan Jayasinghe, MBBS, FRACP, PhD, Varghese Paul, MD, DM, Sharmalar Rajendran, MBBS, FRACP

Chronic total occlusions (CTOs) present one of the most challenging obstacles to interventional cardiologists in the current era. Technical difficulties associated with percutaneous coronary intervention (PCI) of CTOs are reflected by lower success rates of the procedure (approximately 60–80%) compared to other lesion subsets.1–3 Furthermore, there are substantial risks associated with this procedure. Recanalization of a CTO may be complicated by extensive coronary dissection or perforation.4 Radiation skin injuries during long complicated CTO procedures are not uncommon.5 Further, the use of excessive intra-arterial contrast, usually required in this procedure, carries a moderate risk of contrast- induced nephropathy.6 The latter is associated with a more adverse clinical outcome.6,7 Nevertheless, successful revascularization of CTOs is linked with improved symptomatic as well as prognostic outcomes,1,3,4,8 which has rekindled interest in this area.
Currently, a CTO is defined as a complete occlusion (thrombolysis in myocardial infarction [TIMI] grades 0 and 1 flow) for at least 3 months or more. Several studies have reported clinical and angiographic predictors of technical success rates for CTO interventions.1,9,10 We are proposing a novel classification system for CTOs addressing the relationship between the degree of technical difficulty (based on angiographic findings) and the potential risk of the procedure. The purpose of this classification is to provide interventional cardiologists with an objective tool to make a balanced, informed decision prior to attempting an antegrade PCI approach to treat CTOs.
This system is based on the technical difficulty of recanalizing the vessel (Grade A) and the risk of adverse outcomes (Grade B). The greater the technical difficulties of the procedure, the higher the “A” ranking, while a higher “B” classification is associated with an incremental risk in attempting to reopen the artery. The final classification is specified as an “AB” grading.

Classification “A” grading: Technical challenges of recanalizing CTOs
“A0” grade reflects a relatively higher possibility of technical success.
The presence of the following features places the lesion at an “A0” grade:
• A stem of patent vessel longer than 10 mm;
• No branching vessels originating within 5 mm of the occlusion;
• Tapering configuration or a visible track;
• No evidence of calcification on fluoroscopy;
The absence of any single feature places the lesion at the next higher grade.

“A1” grade reflects a relatively lower possibility of reopening with a guidewire and subsequent angioplasty.
Presence of any one of the following features places the lesion at an “A1” grade:
• A stem of patent vessel shorter than 10 mm proximal to the occlusion;
• Presence of branching vessels originating within 5 mm of the occlusion;
• Blunt configuration of the leading edge with no visible track;
• Evidence of some calcification on fluoroscopy.

“A2” grade indicates the highest technical difficulty in tackling CTOs, and rates of successful PCI are likely to be very low.
The presence of any one of the following features places the lesion at an “A2” grade:
• Ostial total occlusion;
• Total occlusion precisely at a bifurcation point;
• Significant calcification on fluoroscopy;
• Long lesion as evidenced by retrograde filling of the distal segment.

Classification “B” grading: Risk associated with attempts at reopening

“B0” grade denotes a relatively low risk of adverse outcomes and is characterized by the presence of any of the following features:
• Absence of bridging collateral vessels;
• Absence of an aneurysmal appearance at the point of occlusion or in close proximity;
• Presence of good distal vasculature as seen by retrograde filling via collaterals from other arteries.

On the contrary, the absence of the above-mentioned features (“B1” Grade) signify a high risk of adverse outcomes.
The final classification is a combination of Grades “A” and “B”, thus taking into consideration the practical complexities and the risks associated with attempts to reopen an occluded artery.

Grade “AB” classification overview
• A0 B0 – High probability of reopening, with low risk;
• A1 B0 – Lower possibility of reopening, but the risk is low;
• A2 B0 – Significantly difficult lesion to reopen, but with low risk;
• A0 B1 – High probability of reopening, but at the cost of high risk;
• A1 B1 – Lower probability of reopening, with high risk;
• A2 B1 – Technically the hardest, with high risk.

Discussion

We present a simple CTO classification system, taking into account the technical difficulties and the risks associated with attempting to treat a CTO. This classification is partly based on findings of several studies that have shown angiographic predictors of successful PCI of CTOs.1,9,10
These include factors such as length of the occlusion, blunt stump of the occlusion, presence of bridging collaterals and coronary calcification. Transluminal coronary calcification, in particular, represents an important impediment to successful recanalization of CTOs,10 and thus represents an integral part of the proposed classification which requires adequate evaluation prior to attempting this procedure.
Until recently, there has been little evidence of potential benefit of recanalizing a CTO which, coupled with the technical complexities, may explain the disparity between the frequency of occurrence and the actual attempts of PCI in CTOs.11 A number of studies have now shown that successful CTO revascularization not only provides relief of symptomatic ischemia, but may prolong survival as well.1,3,4,8
The use of this classification system in planning an optimal strategy, together with recent advances in technologies for CTO revascularization12– 15 such as laser guidewire, optical coherence reflectometry, blunt microdissection catheter and drug-eluting stents, may aid in overcoming the formidable challenges in PCI of CTOs.

Conclusion
We are proposing a simple classification system that is based on the technical difficulties and the risks associated with attempting an antegrade approach of PCI of CTOs, which will hopefully provide interventional cardiologist a balanced approach in attempting this complex procedure whilst considering the associated potential consumption of resources, time and radiation exposure.

 

References: 

References

1. Noguchi, T, Miyazaki MS, Morii I, et al. Percutaneous transluminal coronary angioplasty of chronic total occlusions. Determinants of primary success and long-term clinical outcome. Catheter Cardiovasc Interv 2000; 49: 258– 264.
2. Prasad A, Rihal CS, Lennon RJ, et al. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: A 25-year experience from the Mayo Clinic. J Am Coll Cardiol 200749: 1611– 1618.
3. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: A 20-year experience. J Am Coll Cardiol 2001; 38: 409– 414.
4. Stewart JT, Denne L, Bowker TJ, et al. Percutaneous transluminal coronary angioplasty in chronic coronary artery occlusion. J Am Coll Cardiol 1993; 21: 1371– 1376.
5. Suzuki S, Furui S, Isshiki T, et al. Patients' skin dose during percutaneous coronary intervention for chronic total occlusion. Catheter Cardiovasc Interv 2007; 71: 160– 164.
6. Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004.; 93: 1515– 1519.
7. Chen SL, Zhang J, Yei F, et al. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. Int J Cardiol 2007 Jul 23 [Epub ahead of print].
8. Aziz S, Stables RH, Grayson AD, et al. Percutaneous coronary intervention for chronic total occlusions: Improved survival for patients with successful revascularization compared to a failed procedure. Catheter Cardiovasc Interv 2007; 70: 15– 20.
9. Dong S, Smorgick Y, Nahir M, et al. Predictors for successful angioplasty of chronic totally occluded coronary arteries. J Interv Cardiol 2005; 18: 1– 7.
10. Soon KH, Cox N, Wong A, et al. CT coronary angiography predicts the outcome of percutaneous coronary intervention of chronic total occlusion. J Interv Cardiol 2007; 20: 359– 366.
11. Christofferson RD, Lehmann KG, Martin GV, et al. Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol 2005; 95: 1088– 1091.
12. Hoye A, Onderwater E, Cummins P, et al. Improved recanalization of chronic total coronary occlusions using an optical coherence reflectometry-guided guidewire. Catheter Cardiovasc Interv 2004; 63: 158– 163.
13. Saito S, Tanaka S, Hiroe Y, et al. Angioplasty for chronic total occlusion by using tapered-tip guidewires. Catheter Cardiovasc Interv 2003; 59: 305– 311.
14. Yang YM, Mehran R, Dangas G, et al. Successful use of the Frontrunner catheter in the treatment of in-stent coronary chronic total occlusions. Catheter Cardiovasc Interv 2004; 63: 462– 468.
15. Ge, L, Iakovou, I, Cosgrave, J, et al. 2005. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. Eur Heart J 26: 1056– 1062.

No votes yet

All Subscriptions are FREE to qualified cardiology professionals

#

  • Subscribe to:
  • Journal
  • Digital Journal
  • E-News
  • RSS feed

CLICK HERE TO CONTINUE »

CME Showcase

Diagnosing Coronary Artery Disease: Advanced Cardiovascular Imaging Solutions

Complimentary accredited web archive
This activity is intended for physicians, nurses, and technologists.

Treatment Options for the AF Patient
Complimentary Accredited Dinner Symposium
This activity has been developed for physicians, nurses, and technologists who treat patients with arrythmias.


A-fib Ablation:
Practical Solutions
for the Real World

Complimentary Accredited Lunch Symposium
This activity has been developed for physicians, nurses, and technologists who treat patients with atrial fibrillation.


New Standards of Care for CRMD Antibiotic Protection
Complimentary CME Accredited Webcast
Dates: November 18, 2008 Time: 6:00 pm ET November 19, 2008 Time: 3:00 pm ET
This activity is sponsored by the North American Center for Continuing Medical Education.
LUMEN 2009 - THE SYMPOSIUM ON OPTIMAL TREATMENTS FOR ACUTE MI
Live Symposium Date: February 26-28 Location: Loews Miami Beach Hotel Miami Beach, Florida 33139
This activity is sponsored by the North American Center for Continuing Medical Education.
CARDIAC PET: Optimizing CAD Patient Management with Diagnostic Confidence
A Complimentary CME Accredited Lunch Symposium
Date: Friday, September 12, 2008 12:00 pm - 1:15 pm Location: Hynes Convention Center 900 Boylston Street, Room 304 Boston, MA 02115
This activity is supported by an educational grant from Bracco Diagnostics Inc.

REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.

  • CathLab Digest
  • EP Lab Digest
  • Vascular Disease Management
  • Cath Lab Basics